Drug Discovery Ai Pharmaceutical Research News New Developments September 2026 — Latest Developments and Key Updates

Novo Nordisk announced a partnership with Anthropic to use the Claude AI system for drug discovery across multiple therapeutic areas, aiming to accelerate the identification of promising therapeutic candidates and reduce early‑stage research timelines.

Anthropic will supply its Claude large language model, trained on biomedical literature, to help Novo’s scientists analyze chemical structures, predict molecule behavior, and prioritize experiments through data‑driven decision making, improving efficiency in the discovery pipeline.

AI drug discovery market is projected to reach $13.8 billion by 2033, reflecting rapid growth as pharmaceutical firms adopt machine‑learning tools to cut costs and shorten time to market, with AI tools becoming standard in early research.

Industry analysts say AI‑driven platforms